Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines : an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Toback, S, Galiza, E, Cosgrove, C, Galloway, J, Goodman, A L, Swift, P A, Rajaram, S, Graves-Jones, A, Edelman, J, Burns, F, Minassian, A M, Cho, I, Kumar, L, Plested, J S, Rivers, E J, Robertson, A, Dubovsky, F, Glenn, G, Heath, P T & 2019nCoV-302 Study Group 2022, 'Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines : an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial', The Lancet. Respiratory medicine, vol. 10, no. 2, pp. 167-179. https://doi.org/10.1016/S2213-2600(21)00409-4